ORIC
Oric Pharmaceuticals, Inc.
+0.35 (+2.79%)12.89USD337K成交股數1.3B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 36.3M | 31.4M | 25.9M | 28.8M | 30.5M | 24.6M | 31.2M | 28.9M | 22.0M | 24.5M | 22.4M | 18.8M |
| 銷售管理費用 | 9.0M | 8.2M | 8.7M | 7.9M | 8.5M | 8.1M | 7.1M | 7.1M | 7.0M | 6.9M | 6.3M | 6.2M |
| 營業利益 | −45.3M+16% | −39.6M+21% | −34.6M-10% | −36.7M+2% | −39.1M+35% | −32.7M+4% | −38.3M+34% | −36.0M+44% | −29.0M | −31.4M | −28.7M | −25.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −41.5M+14% | −35.8M+19% | −30.5M-12% | −32.6M+2% | −36.4M+45% | −30.0M+6% | −34.6M+36% | −32.0M+39% | −25.0M | −28.3M | −25.5M | −22.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.38-19% | -0.34-19% | -0.25-49% | -0.33-27% | -0.47+27% | -0.42-14% | -0.49+11% | -0.45-10% | -0.37 | -0.49 | -0.44 | -0.50 |
| 稀釋股數 | 108M | 105M | 87.8M | 99.0M | 78.1M | 71.0M | 70.5M | 70.3M | 67.3M | 51.5M | 57.4M | 45.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 37.5M | 56.4M | 45.7M | 49.7M | 75.9M | 49.3M | 44.2M | 49.8M | 56.4M | 23.4M | 26.2M | 104M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 405M | 437M | 409M | 431M | 347M | 243M | 302M | 329M | 351M | 252M | 274M | 292M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 23.4M | 21.2M | 24.5M | 24.3M | 22.9M | 23.1M | 28.1M | 26.5M | 22.1M | 27.9M | 26.9M | 23.0M |
| 股東權益 | 381M | 416M | 384M | 407M | 324M | 220M | 274M | 302M | 329M | 224M | 247M | 269M |
| 負債比 | 5.8% | 4.9% | 6.0% | 5.6% | 6.6% | 9.5% | 9.3% | 8.1% | 6.3% | 11.1% | 9.8% | 7.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −32.4M-0% | – | – | – | −32.5M | – | – | −30.2M | – | – | – |
| 資本支出 | – | 2K | – | – | – | 387K | – | – | 218K | – | – | – |
| 自由現金流 | – | −32.4M-1% | – | – | – | −32.9M | – | – | −30.4M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −129M | –% | -1.47 | −112M |
| FY2024 | – | – | −128M | –% | -1.83 | −114M |
| FY2023 | – | – | −101M | –% | -1.96 | −86.5M |
| FY2022 | – | – | −89.1M | –% | -2.25 | −77.2M |
| FY2021 | – | – | −78.7M | –% | -2.07 | −60.5M |
| FY2020 | – | – | −73.7M | –% | -3.36 | −45.9M |
| FY2019 | – | – | −26.9M | –% | -14.15 | −24.3M |
| FY2018 | – | – | −21.4M | –% | -12.32 | −21.2M |